Sanarus introduces breast biopsy
Pleasanton, CA-based Sanarus Medical may soon bring to market an ultrasound-guided biopsy tool called Centrica. The product, described as a rotational core biopsy system, uses a new approach to breast tissue sampling that the company considers more
Pleasanton, CA-based Sanarus Medical may soon bring to market an ultrasound-guided biopsy tool called Centrica. The product, described as a rotational core biopsy system, uses a new approach to breast tissue sampling that the company considers more cost-effective and less invasive than open, surgical biopsy options. The procedure creates a 3 to 4-mm incision in the breast and requires no general anesthesia or stitches. Under ultrasound visualization, a small needle is placed directly into the tissue. Once placement is confirmed via ultrasound, the immobilized lesion is “stick frozen” for a few seconds, which secures the targeted tissue and enables a large tissue sample to be removed for evaluation. Centrica, which has been cleared by the FDA, is the first in a series of ultrasound-guided technologies being developed by Sanarus.
GE HealthCare Debuts AI-Powered Cardiac CT Device at ACC Conference
April 1st 2025Featuring enhanced low-dose image quality with motion-free images, the Revolution Vibe CT system reportedly facilitates improved diagnostic clarity for patients with conditions ranging from in-stent restenosis to atrial fibrillation.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
